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Peripheral T lymphocytes express plasma membrane receptors specific for for-
eign antigen that are composed of two disulfide-linked proteins containing constant
and variable regions (1-3) . This dimer is associated with a complex of several invar-
iant proteins collectivelytermedCD3 (4, 5) . Based on biochemical and genetic data,
two forms ofTCRs have been identified : those containing a and a proteins which
are found on the majority of peripheral T cells (1-3), and those made up of 'y and
6 chain heterodimers (6-8) . The latter TCRs are present on some murine, avian,
and human CD4-CD8- thymocytes and peripheral T cells (7, 9-11) and are found
on murine Thy-1 + dendritic epidermal cells in the skin (12-14) . Recently we (15),
and subsequently others (16), demonstrated that a major population of murine
CD8+ T cells found in the small intestine, termed intraepithelial lymphocytes (IEL),'
express the y/S type of TCRs.
Recently, several laboratories have demonstrated that some y, S T cells can react
with mycobacterial antigens (17-19) or with tetanus toxoid (20) . In the case oftetanus
toxid, human class I-restricted CD8' y, S T cells were shown to be reactive. In
other cases the response to mycobacterial antigens by CD4-8- T cells was either
not MHC restricted (17, 18) or was restricted to as yet undefined restricting ele-
ments (19) . In themouse, IEL are unusual amongT cells in that a large proportion
ofCD3+8+ cells are Thy-1 - (21, 22) . In addition, some IEL express the leukocyte
common antigen (T200)-associated carbohydrate differentiation antigen, CTl, an
antigen not present on other peripheral T cells (23, 24) . IEL are also functionally
distinct from other peripheral T cell populations, in that freshly isolated IEL are
cytolytic, although their specificity is unknown (15). However, externally derived
stimuli, perhaps bacterial in nature, are required for induction of lytic activity in
IEL since IEL from germ-free mice are not cytolytic (25) . Lytic activity resides in
the Thy-1+ IEL subset and this population is absent in IEL from germ-free mice.
Thus, IEL represent a distinct lineage ofT cells basedon phenotypicand functional
characteristics, not the least ofwhich is the predominant expression ofTCR ,y/&
To further characterize IEL we developed mAbs specific forTCRy/& Fluores-
cence analysis and biochemical studies using this panel ofmAbs demonstrated marked
heterogeneity in the TCRs ofIEL . Moreover, the constitutive lytic activity and the
Thy-1t phenotype ofIEL was not restricted toTCRy/S+ IEL, but TCRs/fl+ IEL
I Abbreviations used in this paper . IEL, intraepithelial lymphocytes; LN, lymph nodes .
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also exhibited these characteristics. Thus, the distinct attributes of IEL appear to
be regulated by the intestinal milieu and their anatomical location rather than a
priori expression of a particular subclass of TCRs.
Materials and Methods
Purification ofMurine IEL.
￿
IEL were isolated essentially as previously described (15). Briefly,
the small intestinesfrom 4-10 mice were cut into 5-mm pieces that were then stirred at 37°C
in HBSS with the addition of 1 mM dithioerythritol. The resulting supernatants containing
a mixture oflymphocytes and epithelialcells were then centrifuged through a 44/67.5 % Per-
coll gradient. Cells at the interface were panned on petri dishes coated with an anti-CD8
mAb. The final populations were 88-95% CD8'.
Animals.
￿
Adult Armenian hamsters were purchased from Cytogen, Cambridge, MA.
C57BL/6J and BALB/cJ mice were obtained from TheJackson Laboratory, Bar Harbor, ME.
TCell Hybrids.
￿
T cell hybrids used in this study were DN2 .9, DN7 .1.13, DN7.3, DN12.1
(26), generously provided by Ada Kruisbeek(National InstitutesofHealth, Bethesda, MD);
FT45.1 and PDN3.1 (27) were provided byJeff Bluestone (University of Chicago, Chicago,
IL); and 33BTE.67.1 was provided by Willi Born (NationalJewish Hospital, Denver, CO).
MonoclonalAntibodies.
￿
mAbs used for these studies were: 3.168 (anti-CD8; reference 28)
13/2.3 (antiT200; 29), CTl (30), T24 (antiThy-1; 31), 13.4 (antiThy-1.2; 32) 145-2CII (a
hamster mAb specific for the CD3 c--chain; 33), H57.597 (a hamster mAb that recognizes
all TCRa/16; generously provided by Dr. Ralph Kubo, National Jewish Hospital; 34) and
RL172 (anti-CD4; 35).
Production ofmAbs.
￿
Armenian hamsters were immunized in the rear footpads four times
over a 2-mo period with 5-10 x 106 C57BL/6J IEL per footpad. For injection, the IEL were
resuspended in normal saline and were either viable or lethally irradiated. 3 d after the last
injection, popliteal lymph node cells were fused with the murine myeloma SP2/0 at a ratio
of 4:1 (lymph node/myeloma) in 1 ml of 50o7o polyethelene glycol (PEG-1450; J. T. Baker
Chemical Co., Phillipsburg, NJ) as previously described (36). The cells were then distributed
in 96-well microtiter plates with HAT medium.
Screening ofFusions.
￿
Culture supernatants from growth-positive wells were tested for their
ability to redirect lysis of the Fc receptor' DBA/2 mastocytoma P815 by IEL (37). We have
previously shown that freshly isolated murine CD8' IEL are constitutively lytic. 100 pl of
culture supernatant was added to 2.5 x 103 Na"Cr-labeled P815 cells. Freshly isolated IEL
were added to each well at a concentration of 105 cells per well followed by a 5-h incubation
at 370C. Percent specific lysis was calculated as 100 x [(cpm released with effector cells -
cpm released alone)/(cpm released by detergent - cpm released alone)]. Cells from wells
that resulted in >10% lysis were cloned twice by limiting dilution at a concentration of 0.5
cells/well in 96-well microtiter plates with 106 BALB/cJ irradiated spleen cells per well.
Immunofuorescent Staining.
￿
IEL and murine spleen cells were resuspended in PBS/0.2
BSA/0.1% NaN3 followed by incubation at 4°C for 30 min with 200 pl of culture superna-
tant from hybridomas that redirected lysis. In other experiments, cellswere incubated with
appropriate dilutions of purified antibodies or antibodies coupled to biotin or fluorescein
isothiocyanate. Cells were washed twice and incubated for 30 min with a FITC-coupled goat
anti-hamster Ig (Cappel Laboratories, Malvern, PA) or avidin-phycoerythrin. Cells were
then washed three times and resuspended at 106 cells/ml for cytofluorimetric analysis. Rela-
tive fluorescent intensities of individual cells were measured with a cytofluorograph (no. 50H;
Ortho Diagnostic Systems Inc., Westwood, MA). Forward angle light scatter was used to ex-
clude dead and aggregated cells. The results are presented as fluorescence histograms with
the relative number of cells on a linear scale plotted vs. the relative fluorescence intensity
on a logarithmic scale, both in arbitrary units.
Radioimmunoprecipitation.
￿
Cell surface proteins of IEL were radioiodinated by the Iodogen
method (38). IELs were washed and resuspended in lysis buffer (PBS, 0.5% NP-40, 2 mM
PMSF, 20 IU/ml aprotinin, 10 mg/ml BSA) and incubated on ice for 15 min. Lysates were
centrifuged at 13,000 g for 20 min and precleared with Pansorbin (Calbiochem-Behring Corp.,
La Jolla, CA) followed by incubation with purified GLI, 2, 3, 4, or 5 coupled directly toGOODMAN AND LEFRANCOIS
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Sepharose 4B and 4°C overnight . The resulting precipitates were analyzed by SDS-PAGE
using a 12.5% acrylamide gel in the absence or presence of5% 2-ME . Endoglycosidose F
treatments were carried out on immunoprecipitates according to themanufacturer's specifica-
tions (N-glycanase ; Genzyme, Cambridge, MA) . After drying, the gels were subjected to
autoradiography at -70°C with Kodak XAR5 x-ray film and Dupont Cronex intensifier
screens .
Results
To obtain mAbs that would react with native cell surface TCRs, we immunized
hamsters with intact purifiedIELandgeneratedhybridomas by fusingimmunelymph
node cells with the murine myeloma SP2/0. Since IEL are constitutively cytolytic,
a redirected lysisassaywasused fordetection ofmAbs specific formolecules capable
of inducing lysis . This assay uses an Ig Fc receptor-expressing target cell and relies
on crosslinkingby themAbof relevant cell surface proteins ofIEL to the Fc receptor
to trigger lysis . In this way several mAbs were identified that were able to redirect
lysis of IEL and were specific forTCRy/& These mAbs were further screened by
fluorescence analysis of binding to lymph node T cells and to IEL . The IEL in all
experiments unless otherwise stated were 85-95% CD3 +8+ with <5% of the cells
being either surface Ig+ or CD4+ and 10% or fewer being nonlymphoid epithelial
elements . The binding of five of the mAbs, termed GLl through GL5, to IEL is
depicted in Fig . 1, A andB. IEL from C57B1/6J mice (B6) were 40-50% GLl+ and
15-20% GL2+ (Fig . 1 A) . GL3 andGL4 reacted with 70-80% ofIEL and 40-50%
were GL5+ . The intensity ofGL4 staining was consistently less than that observed
using GL3 . Purified lymph node (LN) T cells were also tested with the GL mAb
series and <3% ofLNT cells were positive using any ofthe mAbs (as an example,
GL3 binding is shown in Fig. 1 C) . The hamstermAb H57, which reacts with all
TCRa/f, stained nearly all LN T cells, but only 20-25% of B6 IEL (Fig . 1 C) .
This result was consistent with our previous demonstration that 7-10% ofB6 IEL
FIGURE 1 . Reactivity of anti-
CC mAb with IEL . Purified
IEL (A, B, D) or purified lymph
node T cells (C) were reacted
withthe indicatedmAbfollowed
by stainingwith an FITC-con-
jugated goat anti-hamster Ig re-
agent . Individual cells were then
analyzed by fluorescence flow
cytometry .1572
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are stained by the V08-reactive mAb F23.1 (23), which reacts with -20% of pe-
ripheralT cellsfrom this strain. Together, mAbsGL3 and H57 were abletoidentify
all CD3+ IEL (see below).
Since some ofthe mAbs reacted with IEL subpopulations we wished to examine
their ability to trigger TCRmediated lytic activity ofthe respective subsets. Purified
GLl, GL2, and anti-CD3 were compared in the redirected lysis assay (Fig. 2). All
ofthemAbs couldtrigger lysis by IEL, with anti-CD3 beingthe most efficient. The
levels oflytic activity obtained using GLl and GL2 also correlated with the number
ofcells expressing eachofthese determinants, with GL2, which reacts with 15-20
ofB6 IEL, triggeringlow levels ofactivity. GL3-GL5 also efficiently triggeredlysis.
Thus, all of the subpopulations identified by the GL mAb were cytolytic.
To assess the reactivity of the GL mAb with TCR proteins IEL were radioiodi-
nated and lysates were subjected to immunoprecipitation. Several interesting fea-
tures ofIEL TCR proteins were evident (Fig. 3). When the precipitates were ana-
lyzed under nonreducing conditions two protein species of apparentMr 78,000 and
73,000 were presentinprecipitates fromGLl, 3, 4, and 5. In contrast, GL2 precipi-
tated only the 78,000 Mr dimer (Fig. 3 A, lane 2). Analysis under reducing condi-
tions revealed that GLl, 3, 4, and GL5 precipitated 46,000 and 42,000 S Mr pro-
teins and 35,000 and 34,000 y Mr proteins. These results were identical to those
obtained by precipitation with an anti-Cy sera (15) or with anti-CD3 . In contrast,
GL2 reacted primarily with TCRs containing the higher Mr 6 chain of46,000, con-
sistent with the precipitation of only the 78,000 Mr dimer by this mAb. However,
it became clear that a third 6 protein of 43,000 Mr was also precipitated by GL2
(Fig. 3, lane 2, arrow). The presence oftwo distinct TCR heterodimers on IELwas
further examined by two-dimensional nonreducing/reducing electrophoresis (Fig.
4). While the anti-CD3 and GLl mAb precipitated dimers that contained two S
chains thatwere easily separated, the GL2 mAb reactedonlywith dimers containing
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FIGURE 2.
￿
IEL subpopulations are constitutively cytolytic.
Serial dilutions of IEL were incubated for 5 h at 37°C with
2.5 x 103 5'Cr-sodium chromate-labeled P815 target cells
that had been previously incubated with 2 jig/ml of anti-
CD3 ("), GLl (A), GL2 (/), ormedium alone(O). Spon-
taneous release was <10%.GOODMAN AND LEFRANCOIS
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FIGURE 3 .
￿
Immunoprecipitation ofTCR--y/S by the GL mAb . IEL were surface labeled with
1251 and lysates were subjected to immunoprecipitation with GL1 (lane 1) ; GL2 (lane 2); GL3
(lane 3) ; GL4(lane 4); or GL5(lane 5) . The precipitates were analyzed on a 12.5% SDS-poly-
acrylamide gel under nonreducing (A) or reducing (B) conditions followed by autoradiography .
FIGURE 4 .
￿
Two-dimensional electrophoretic analysis ofTCR-y/S ofIEL . IEL immunoprecipi-
tates were separated undernonreducingconditions in a 12.5% SDS-polyacrylamide gel in 3-mm
tubes followed by separation in the second dimension under reducing conditions in a 12 .5% slab
gel. Precipitations were carried out on digitonin lysates with the indicated mAb .1574
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the higherMrS proteins . This experiment also demonstrated that similar 'y chains
were able to associate with the high and lowMr S proteins, although we do not know
whether different V regions are being used by y chains with similarMr . Thus, not
only do the GL mAb subdivide the IEL on the basis of cell surface binding but this
heterogeneity was manifested in the chain composition of the TCRs recognized by
the mAb .
To determine whether the distinct TCR proteins were due to differences in
asparagine-linked glycosylation GLI and GL3 immunoprecipitates were subjected
to endoglycosidase F treatment (Fig. 5) . The two major S proteins of 46,000 and
42,000M r were each reduced in molecular weight by "6,000 after Endo F diges-
tion, while the major 34,000Mry protein was reduced by 3,000 . These results sug-
gest that two N-linked oligosaccharide chains were present on the S chains and that
a single N-linked oligosaccharide was present on the 34,000M r 'y chain, consistent
with previous reports . Moreover, the presence of two major S proteins was not due
to heterogeneity of N-linked glycosylation .
Two-color fluorescence analysis was used to determine the interrelationships be-
tween the IEL subsets delineated by the GL mAb. Simultaneous staining with GL1
and GL2 showed that 95-98% ofGL2 + cells were contained within the GLl' popu-
lation (Fig . 6 B) . Thus, GL2 identified a subset ofGLV IEL that preferentially
expressed the highM r S proteins as shown above . Sequential immunoprecipitations
revealed that the 46,000Mr S protein contained within the GLl + population was
entirely GL2' (see below). However, preclearance of lysates with GL2 followed by
precipitation with GL3 indicated that otherGL2- 46,000M rS proteins were present
(Lefrancois, L ., andT Goodman, unpublished results) . Further fluorescence binding
studies demonstrated that the GL5' subset overlapped completely with the GLV
population . The mAbs were also tested for reactivity with a panel ofTCRy/S'
hybrids derived from fetal thymocytes or from CD4-8- peripheral T cells (Table
I) . The GLI andGL5 mAbs did not react with any ofthe hybrids shown . GL2 reacted
with two hybrids with similar y and S chains (Vy2Cy1NS4). However, GL2 did
not react with other Vy2Cy1 hybrids with as yet uncharacterized S chains, and IEL
contain <5% Vy2' cells . Thus, we can tentatively assign GL2 to VS4 specificity.
GL3 and GL4 reacted with all hybrids tested regardless of y or S chain expression .
FIGURE 5.
￿
Analysis ofN-linked glycansofIEL
TCRproteins . Lysates from 1251 surface-labeled
IELwere subjected to inununoprecipitation with
GLIor GL3coupled to Sephacose4B.The result-
ing precipitates were treated with N-glycanase
(lanes 3, 5) or with reaction buffer without the
enzyme added (lanes 2, 4) for 16 hfollowed by
analysis on a 12.5% SDS-polyacrylamide gel.
(Lane 1) Molecular weight standards ; (lanes 2,
3)GLI precipitate; (lanes 4, 5)GL3 precipitates.s e
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TABLE I
FIGURE 6. Two-color fluorescence analysis of
TCRy/SandThy-1 expression of IEL. Purified
IEL were reacted with FITC-conjugated anti-
Thy-1 mAb(C, D) or GL2 (B)followed by reac-
tion with biotinylated GLI (B, C) or GL2 (D).
Biotinylated mAbs were detected with avidin-
phycoerythrin (PE). Control cells were reacted
with avidin-PEandaFITC-coupled goat anti-rat
Ig reagent.
Tofurtherdelineate thefine specificity ofthe mAb, competitivebindingstudies were
performed (Table II). Interestingly, binding of GL2 was effectively competed for
by GL3 and GL4. GL3 and GL4also crossblocked the binding ofeach other. Since
GL2 appears to be specific for aVS4 determinant, GL3 and GL4 can be tentatively
assigned to CS specificity. None ofthe mAbs react with TCR proteins after reduc-
tion and alkylation of the heterodimer, so we have not as yet been able to assign
chain specificities by biochemical means.
We also examined the relationship between Thy-1 expression and the restricted
TCR epitopes. In the experiment shown in Fig. 6 the IEL were 46% Thy-1+, 41%
GLI+ and 1896 GL2+. 17% ofB6 IEL were Thy-l+ GLl+ (C) and 10% were Thy-1+
GL2+ (D). The remaining GL mAbs gave similar results: both Thy-1+ and Thy-1-
IEL were stained. Thus, although IEL that express Thy-1 are cytolytic, while
Thy-1 - IEL are not, there did not appear to be a partitioning ofa particular TCR
subtype into either class of IEL.
The absenceofThy-1 and the presence ofthe CTl carbohydrate antigen on some
IEL serve to distinguish these cells from other peripheral Tcells. No other mature
T lymphocytes yetdescribed have thesecharacteristics. Moreover, few murine TCR
y/S+ T cells other than IEL express CD8. Our original observations (15) led us to
suggest that the expression ofthese receptors was linked to the distinct phenotype
of IEL. To address this possibility we analyzed the expression of Thy-1 and CT1
Reactivity of the GL mAb with TCR-y/B* T Cell Hybrids
The hybrids were reacted with FITC-coupled GL mAb and analyzed by fluorescence flow
cytometry.
mAb
DN2.9
Vy1Cy2
DN12.1
VylCy4
Hybrids
DN7.1 .13
Vy4Cy1
and TCR
DN7.3
Vy2Cy1
proteins
FT45.1
Vy3Cy1
expressed
PDN3 .1
Vy2CyINb4
33BTE.67.1
Vy2Cy1Nb4
GLI - - - - - - -
GL2 - + +
GL3 + + + + + + +
GL4 + + + + + + +1576
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Saturatinglevels ofunlabeled mAb were incubated with IEL followed by wash-
ing and incubation with FITC-coupled mAb. The cells were then analyzed by
fluorescence flow cytometry.
on TCRa/a+ IEL with the H57 mAb that is reactive with all TCRa//3 We first
compared the populations stained by this mAb with those stained by GL3, since
the latter appears to react with all TCR,y/& In the experiment shown the IEL were
67% GL3+, 25% H57+, 46% CT1+, 26% Thy-1+, and 8% CD3-. GL3 and H57
stained mutually exclusive IEL subpopulations and together reacted with all CD3+
IEL. Simultaneous staining with GL3 and antiThy-1 or with the CTI mAb indi-
cated that 50% ofIEL were Thy-1" GL3+ (74% ofGL3+ IEL, Fig. 7 C), while 32%
were CTl+ GL3+ (48% ofGL3+ cells; Fig. 7 D). Similar reactions using H57 rather
than GL3 revealed that a substantial portion of TCRa/a+ IEL were Thy-1-. In
this experiment, 18% of IEL, representing 72% of TCRa/a+ cells were Thy-1-
H57+ (Fig. 7 E). Moreover, 12% of IEL were CTI+ H57+, or 48% ofTCRa/o-
expressing IEL (Fig. 7 F). These results indicate that the unusual Thy-1- CT1+
phenotype was not restricted to TCRy/S+ IEL but that similarTCRa/a+ IEL were
also present. Thus, IEL were of a distinct phenotype that was likely to be due to
G&Rlg-FRc
￿
H57
FIGURE 7.
￿
Thy-1 and CT1 expression are not linked
to IEL TCR expression. TEL were analyzed by
fluorescenceflow cytometry after reactionwith FITC-
conjugated H57(antiTCRa/fl) or GL3 followed by
incubation with biotinylated GL3, antiThy-1, or CTl
GL3
￿
GL3
￿
as indicated.
J
t7
TABLE II
Competitive Binding Analysis of the GL mAb
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mAb
GL4 GL5
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GL2 - + + + -
GL3 - + + + -
GL4 - + + + -
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FIGURE 8.
￿
TCRa/13* IEL are constitutively cytolytic.
The redirected lysis assay (described in the legend to Fig.
2) was used to assay lytic activity ofTCR-y/6' versus TCR
a/0' IEL. P815 target cells were preincubated with 2 F+g/ml
of GL3 (A), H57 (0), or with medium alone (O). Assay
time was 5 h.
their anatomical site and specialized environment, rather than the type ofTCR that
was being used.
Since TCR-y/S+ IEL were constitutively cytolytic upon isolation, we wished to
determine if TCRcdo' IEL also exhibited this characteristic. IEL were isolated and
titrated into the redirected lysis assay with the addition of either GL3 or H57. As
can be seen in Fig. 8, relatively high levels of lytic activity were detectable using
GL3. Furthermore, H57 was also capable of redirecting lysisby IEL albeit at a lower
level than GL3 . This result is consistent with only 20% of IEL being H57 + in this
experiment. Similar results were obtained using several IEL preparations. It should
be noted that CD8+ peripheral T cells isolated by anti-CD8 panning are not lytic
in this assay. These results suggest that the functional programming of IEL in vivo
appears to be independent of TCR utilization.
Discussion
The results presented demonstrated marked heterogeneity in TCRy/S of IEL.
The TCRy/&-specific mAbs that were generated divided IEL into at least three sub-
populations: GLl+2+, GL1+2- and GL1 -2 -3+ . We believe that the GL3 and GL4
mAbs react with all TCRy/S and may be specific for a determinant present on CS
(Table I). GL2 precipitates only TCRs containing the higher Mr 6 chains, as well
as both observed y chains, and appears to be specific for a V64 determinant (Table
I, Figs. 3 and 4). The predominant y chain mRNA present in IEL has been shown
to contain the V5 variable region sequence (Asarnow, D., L. Lefrancois and J. P
Allison, manuscript submitted for publication; and reference 16), although other
Vy protein mRNAs are also detected in IEL. We have also analyzed IEL with a
Vy3-specific mAb (39) and found that virtually no IEL expressed this receptor. In
addition, Vy2 expression was tested using a V2-specific mAb and <5% of B6 IEL
were V2' (data not shown). Thus, the bulk of IEL appear to use V5-containing
receptors.
Freshly isolated IEL are constitutively cytolytic. Yet, CD8+ IEL do not possess
natural killer or spontaneous cytotoxic abilities (15, 23). In this report we have shown
that all of the subpopulations defined by our mAb were cytolytic, indicating that1578
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a particular subset of IEL expressing certain TCRs were not solely responsible for
the activity (Fig. 2). This point was further exemplified by the demonstration that
IEL expressing TCRa/S also displayed lytic ability, indicating that the intestinal
milieu dictated the functional programming of IEL regardless of TCR utilization.
Intriguing implications for the apparent dichotomy in TCRa/fl versus TCRy/8
expression were suggested by these results. Although murine IEL as a population
were heavily skewed toward TCR-y/S+-bearing cells (,y/S:a/# was N3:1 in B6 mice),
common functional and phenotypic characteristics were observed for both popula-
tions. In particular, a large percentage of both y/S+ and a/fl' IEL were Thy-1 - .
What does this signify in terms of T cell differentiation? In the least, a distinct
pathway of T cell trafficking into the IEL compartment would necessarily exist. It
is also possible that some T cell differentiation occurs in situ in the gut mucosa.
Since cytolytic IEL are Thy-1 + but noncytolytic IEL are Thy-1 - (25) it is tempting
to speculate that Thy-1 - IEL once activated differentiate into Thy-1 + cells with cyto-
lytic ability. Indeed, our preliminary results suggest that this phenomenon can occur
in vitro in response to activation by antiTCR mAb (Lefrancois, L., and T Goodman,
unpublished results). Whether the Thy-1 - IEL arise from an extrathymic differen-
tiation pathway or via the thymus as Thy-1 + or Thy-1 - precursors remains to be
seen. Thy-1 - TCR* thymocytes have not been described. It is also possible that
seeding of the gut mucosa by T cells or their precursors occurs early in ontogeny
and is not active in the normal, mature animal. In any case a mechanism for IEL
precursors or their progeny to specifically home to the intestinal mucosa must exist.
More precisely, IEL would require a mechanism for trafficking to the intestinal epi-
thelium since other mucosal T cell populations such as lamina propria and Peyer's
patch lymphocytes are not phenotypically similar to IEL (40). It is interesting to
note that IEL do not express the MEL-14 lymphocyte homing receptor (23). It has
also recently been demonstrated that a second type of homing receptor exists that
is used by Peyer's patch lymphocytes, although it was not determined whether IEL
expressed this receptor (41). Perhaps a third type of homing receptor is required
for proper IEL trafficking. The question ofIEL specificity remains to be answered.
Although environmental stimuli can clearly influence the cytolytic activity and Thy-1
expression of IEL (25) the precise antigen(s) responsible for these effects are not
known. However, in vivo IEL activation occurs over a relatively lengthy time period
(2-4 wk), suggesting that colonization by intestinal bacterial flora may be respon-
sible. Attempts at generating TCRy/S+ virus-specific IEL have thus far failed (data
not shown). We are currently using flora-defined mice to assess the problem of IEL
reactivity. The mAb described here should prove invaluable in further analyzing
the ontogeny and function TCRy/S' T cells.
Summary
The function and structure of the TCR proteins of intraepithelial lymphocytes
(IEL) were examined using a panel of mAbs specific for TCRy/& Three subsets
of TCRy/S+ IEL could be detected with five mAbs, termed GL1-GL5. The mAbs
were able to trigger lysis via crosslinking ofthe IEL TCR and all ofthe subsets were
constitutively cytolytic. Immunoprecipitation of IEL TCR proteins revealed that
the GL2 mAb reacted only with y, S heterodimers containing high Mr S chains,
while the other mAbs precipitated all of the observed y and 6 proteins. Two-colorGOODMAN AND LEFRANCOIS
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fluorescence analysis showed that the GL2' subset was contained within the larger
GLl' subset. The GL3 and GL4 mAbs appear to be specific for all TCR,y/b while
GL2 was V64 specific. Analysis of IEL for TCRci/S expression demonstrated that
x+20% of B6 IEL were TCRci/a' . Interestingly, this population of IEL contained
Thy-1- and CT1' cells, indicating that the unique phenotype of IEL was not re-
stricted to TCR,y/b+ cells. Moreover, the TCRcif' IEL were also constitutively
cytolytic, suggesting that the intestinal milieu was controlling the functional program-
ming of IEL regardless of TCR type. The mAbs reported here as well as the ability
to exploit the distinct phenotype ofIEL should prove useful in determining the function
of IEL and the TCR-y/&
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